XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,336,544 | -20.4% | 68,400 | -10.3% | 0.00% | – |
| Q2 2023 | $2,934,894 | +172.7% | 76,231 | +153.5% | 0.00% | – |
| Q1 2023 | $1,076,170 | +53.3% | 30,069 | +68.9% | 0.00% | – |
| Q4 2022 | $701,854 | -67.1% | 17,800 | -69.9% | 0.00% | – |
| Q3 2022 | $2,134,000 | -24.5% | 59,100 | -36.4% | 0.00% | – |
| Q2 2022 | $2,828,000 | -6.5% | 92,989 | -6.0% | 0.00% | – |
| Q1 2022 | $3,023,000 | -67.0% | 98,891 | -66.2% | 0.00% | – |
| Q4 2021 | $9,154,000 | +70.6% | 293,000 | -16.5% | 0.00% | – |
| Q3 2021 | $5,365,000 | +454.2% | 351,079 | +575.4% | 0.00% | – |
| Q2 2021 | $968,000 | +108.2% | 51,981 | +100.1% | 0.00% | – |
| Q1 2021 | $465,000 | +662.3% | 25,982 | +34.8% | 0.00% | – |
| Q2 2017 | $61,000 | – | 19,277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |